<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01619436</url>
  </required_header>
  <id_info>
    <org_study_id>0279/03.05.2010</org_study_id>
    <nct_id>NCT01619436</nct_id>
  </id_info>
  <brief_title>The Effect of Clonidine in Glycemia During Coronary Artery Bypass Graft With Cardiopulmonary By-pass</brief_title>
  <official_title>The Effect of Clonidine in Glycemia During Coronary Artery Bypass Graft With Cardiopulmonary By-pass.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of Juiz de Fora</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of Juiz de Fora</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is the randomized blind research of the assessment of the different
      levels of glycemia during Coronary Artery Bypass Graft (CABG) with cardiopulmonary by-pass
      (CPB) between clonidine and placebo. As clonidine decrease the inflammatory response during
      cardiac surgery, the investigators would like to know if the glycemia levels in clondine
      group will be lower than placebo group.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>sedation</measure>
    <time_frame>2 years</time_frame>
    <description>Clonidine 2 mg/kg IV. assessment sedation with Ransay scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glycemia</measure>
    <time_frame>2 years</time_frame>
    <description>clonide 2 mg/kg. assessment the glycemia during CPB.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">46</enrollment>
  <condition>Glycemia During Coronary Artery Bypass Graft</condition>
  <condition>Sedation During Pre-anesthetic Medication</condition>
  <arm_group>
    <arm_group_label>clonidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>clonidine 2 mg/kg IV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ringer lactato 1 ml</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Ringer lactato 1 ml IV as Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clonidine</intervention_name>
    <description>bolus, clonidine 2 mg/kg IV</description>
    <arm_group_label>clonidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ringer lactato</intervention_name>
    <description>1 ML ringer lactato IV, as placebo</description>
    <arm_group_label>ringer lactato 1 ml</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective CABG EF &gt; 40% Sinus ritmy

        Exclusion Criteria:

          -  precordialgia emergency surgery combinated surgery not agreement
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>National institut of Cardiology</name>
      <address>
        <city>Rio de Janeiro</city>
        <state>RJ</state>
        <zip>3600/100</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://www.sba.com.br</url>
  </link>
  <link>
    <url>http://www.pubmed.com</url>
  </link>
  <link>
    <url>http://www.capes.com.br</url>
  </link>
  <link>
    <url>http://www.rba.com.br</url>
  </link>
  <link>
    <url>http://www.ovidsp.com</url>
  </link>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 12, 2012</study_first_submitted>
  <study_first_submitted_qc>June 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 14, 2012</study_first_posted>
  <last_update_submitted>June 13, 2012</last_update_submitted>
  <last_update_submitted_qc>June 13, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 14, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of Juiz de Fora</investigator_affiliation>
    <investigator_full_name>Marcello F Salgado Filho, MD</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clonidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

